Advanced Cell Technology: Dr. Robert Lanza, VP of Research & Scientific Development, to Speak at the First Albany Capital Regenerative Technologies Conference

WORCESTER, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC) announced that Dr. Robert Lanza, the company’s Vice President of Research and Scientific Development, will be participating in the First Albany Capital Regenerative Technologies Conference in New York City on Tuesday, September 11, 2007 at 12:00PM EST. Dr. Lanza will be taking part in the Luncheon Panel regarding current issues in stem cell therapy, tissue engineering, and bone regeneration. The conference is expected to include more than 20 private and publicly-traded companies in the regenerative medical technologies industry.

MORE ON THIS TOPIC